Trial Profile
Effect of in Vitro Blocking the Common Beta Chain on the Function of Blood, Bone Marrow and Sputum Cells Collected From Asthmatic Donors.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Trabikibart (Primary)
- Indications Allergic asthma
- Focus Pharmacodynamics
- 22 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 23 Jan 2013 New trial record